# A Single-patient Study of Repeat-dose Administration of Prometic Plasminogen (Human) Intravenous

> **NCT03265171** · — · NO_LONGER_AVAILABLE · sponsor: **Prometic Biotherapeutics, Inc.**

## Conditions studied

- Hypoplasminogenemia

## Interventions

- **BIOLOGICAL:** Plasminogen (Human)

## Key facts

- **NCT ID:** NCT03265171
- **Lead sponsor:** Prometic Biotherapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2020-04-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03265171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03265171, "A Single-patient Study of Repeat-dose Administration of Prometic Plasminogen (Human) Intravenous". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03265171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*